
Glysat PM 2mg/500mg/15mg Tablet SR
Marketer
Events Pharma
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glysat PM 2mg/500mg/15mg Tablet SR
Combiflex-DM 2mg/500mg/15mg Extended-Release Tablets manage blood glucose. Used alongside diet and exercise, this medication improves glycemic control in adult type 2 diabetics. It enhances insulin effectiveness, thus reducing blood sugar. Dosage and duration for Combiflex-DM should strictly follow your physician's instructions. Take with food to prevent gastrointestinal distress. Missed doses should be taken promptly unless the next dose is imminent; in this case, skip the missed dose and resume your regular schedule. Never double the dose. Overdosage can cause hypoglycemia. Concurrent use with other antidiabetic agents, alcohol, or meal skipping may precipitate hypoglycemia; regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and upper respiratory infections. Pre-existing kidney, liver, or heart conditions must be disclosed to your doctor before commencing treatment. Pregnant or lactating individuals require medical consultation. Renal function tests are essential prior to initiating therapy. Limit alcohol consumption as this can heighten the risk of adverse effects.
Uses of Glysat PM 2mg/500mg/15mg Tablet SR
Managing Type 2 diabetes
Major Benefits of Glysat PM 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glysat PM 2mg/500mg/15mg Extended-Release Tablets should be administered with a meal.
Common Side effects of Glysat PM 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glysat PM 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glysat PM 2mg/500mg/15mg Tablet SR whole; do not fracture, crush, or chew it. Administer this extended-release tablet with a meal.
How Glysat PM 2mg/500mg/15mg Tablet SR works:
Glysat PM 2mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. These medications employ diverse mechanisms to achieve superior blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glysat PM 2mg/500mg/15mg SR tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glysat PM 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glysat PM tablets (2mg/500mg/15mg) are likely unsafe for breastfeeding mothers. Available evidence indicates potential transfer to breast milk with consequent risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glysat PM 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Glysat PM 2mg/500mg/15mg SR tablets are contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glysat PM 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. Glysat PM 2mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glysat PM 2mg/500mg/15mg Tablet SR :
Should you forget a Glysat PM 2mg/500mg/15mg SR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glysat PM 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
